Pharma News India

The Indian pharmaceutical industry is growing at a very fast pace. With its fast growth, it is highly imperative to stay updated with the current news and trends in the market. Brand India Pharma gives you the latest pharmacy related news to help you stay updated. Read the latest pharmaceutical news about different sectors and their strategies in the Indian Pharma News section. Get fresh updates from Pharma companies like Natco, Panacea Biotec, Hamsons.
You can bookmark the Indian Pharma News section for the news on pharmaceuticals, drugs and formulations. The Brand India pharmacy news also includes pharmaceutical conference highlights for inquisitive readers.

Sun Pharmaceuticals has received the US Food and Drug Administration's (USFDA) approval for its supplemental new drug application for Ximino, an extended release capsule. This would strengthen Sun's branded dermatology portfolio in the US market.

August 19, 2015: The firm has been building on its dermatology segment and has plans to make it its biggest revenue segment and expects ...


The government has deferred proposed talks on a bilateral trade pact with the European Union (EU) as it is upset with its suspended sale of 700 pharmaceutical products that were clinically tested in India.

August 05, 2015: "The Government of India has taken a decision to defer the proposed talks between the chief negotiators on India- EU Broadbased Investment and Trade Agreement f...


Lupin would be making the highest R&D spend in the pharma industry soon. Lupin has been spending 7.5-8.75 per cent of its turnover on R&D over the last five years and is inching towards 10 per cent soon, while the average R&D spend in the pharma industry has been 5 per cent to 7 per cent.

July 14, 2015: Lupin has transformed itself into a global company with 11 manufacturing sites...


The government is preparing a Rs 500 cr financial package to help Small and Medium (SME) pharmaceutical companies to upgrade their manufacturing facilities and comply with global standards.

New Delhi, July 01, 2015: "We may roll out the financial package by December this year",according to an official from Department of Pharmaceuticals (DoP). The Ministry of Commerce is mulling t...


The Pharma Task Force, headed by Pharmaceuticals Secretary, Mr V K Subburaj has recommended a review of the Drug (Prices Control) Order, 2013 as well as rationalisation of the inverted duty structure on Active Pharmaceutical Ingredients (APIs) to be at par with pharma goods, whereby the excise duty is brought down from the current 10 per cent.

June 23, 2015: The report of the Task...


Comment!
 
 






* Indicates mandatory field.
Please wait while comments are being sent...